Patents by Inventor Steve H. Kye

Steve H. Kye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE
    Publication number: 20220378811
    Abstract: The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS).
    Type: Application
    Filed: May 10, 2022
    Publication date: December 1, 2022
    Applicant: ABBVIE INC.
    Inventors: John HAYSLIP, Steve H. KYE, William B. AINSWORTH
  • VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH A CYP3A INHIBITOR AND AZACITIDINE
    Publication number: 20220370481
    Abstract: The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (MDS).
    Type: Application
    Filed: May 10, 2022
    Publication date: November 24, 2022
    Applicant: ABBVIE INC.
    Inventors: John HAYSLIP, Steve H. KYE, Ahmed SALEM, Jiuhong ZHA
  • ANTIVIRAL COMPOUNDS AND METHODS OF USE
    Publication number: 20150164910
    Abstract: Methods for treating enteroviral infections in cells are provided. Aspects of the methods include inhibiting the replication of enterovirus or replication of other virus and/or inhibiting cell death in a cell infected with enterovirus or other viruses.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 18, 2015
    Inventors: Paul Krogstad, Jun Zuo, Steve H. Kye, Robert D. Damoiseaux